Back to Authors

Dreyling, Martin

A5050368415 | I3018771216

Mayo Clinic

LMU Klinikum

Citations 4

Patient‐centered and proportionate safety reporting in clinical trials facilitates evidence‐based medicine for the benefit of patients and society: An EHA priority

HemaSphere | October 15, 2025 | Volume: 9 | Issue: 10 | Pages: No page available

10.1002/hem3.70239 | PMID 41104378

The CAR-Hematotox Score Identifies Patients at High Risk for Hematological Toxicity, Infections and Poor Clinical Outcomes Following Brexucabtagene Autoleucel in Relapsed/Refractory Mantle Cell Lymphoma

Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 651-653

10.1182/blood-2022-167329

P1100: BRUIN MCL-321: A PHASE 3 OPEN-LABEL, RANDOMIZED STUDY OF PIRTOBRUTINIB VS INVESTIGATOR CHOICE OF BTK INHIBITOR IN PATIENTS WITH PREVIOUSLY TREATED, BTK INHIBITOR NAÏVE MCL (TRIAL IN PROGRESS)

HemaSphere | June 23, 2022 | Volume: 6 | Issue: No issue available | Pages: 990-991

10.1097/01.hs9.0000847268.67095.fc

Maintenance Therapies for Hodgkin and Non-Hodgkin Lymphomas After Autologous Transplantation

JAMA Oncology | February 28, 2019 | Volume: 5 | Issue: 5 | Pages: 715

10.1001/jamaoncol.2018.6278 | PMID 30816957